Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and Aortic Stenosis
Umesh N. Khot(Urology of Indiana), Gary S. Francis, E. Murat Tuzcu(Cleveland Clinic), Gian M. Novaro(Cleveland Clinic Florida), Zoran Popović(Cleveland Clinic), Steven E. Nissen(Cleveland Clinic), Roger M. Mills(Janssen (Belgium)), James D. Thomas(University College London), Donald Hammer
Cited by 278
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
|New England Journal of Medicine|2007|4.7k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k